Specify a stock or a cryptocurrency in the search bar to get a summary
Fisher & Paykel Healthcare Corporation Limited
FSPKFFisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand. Address: 15 Maurice Paykel Place, Auckland, New Zealand, 2013
Analytics
WallStreet Target Price
36.86 AUDP/E ratio
139.2619Dividend Yield
1.3 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures FSPKF
Dividend Analytics FSPKF
Dividend growth over 5 years
61 %Continuous growth
–Payout Ratio 5 years average
76 %Dividend History FSPKF
Stock Valuation FSPKF
Financials FSPKF
Results | 2019 | Dynamics |